• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口咽I期和II期鳞状细胞癌中传统分割放疗(每周五次分割)与改变分割放疗(每周六次分割)的比较:一项机构研究

Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.

作者信息

Poddar J, Sharma A D, Kunikullaya S U, Neema J P

机构信息

Department of Radiotherapy, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.

出版信息

Indian J Cancer. 2017 Jan-Mar;54(1):6-10. doi: 10.4103/ijc.IJC_144_17.

DOI:10.4103/ijc.IJC_144_17
PMID:29199652
Abstract

BACKGROUND

The radiotherapy (RT) dose and fractionation schedule for head and neck cancers for locoregional control and acceptable organ toxicity are still debatable. Accelerated RT includes administration of six fractions per week with the same dose per fraction.

AIM

Comparison of conventional versus accelerated RT in terms of locoregional control, and acute and late radiation toxicity in squamous cell carcinoma oropharynx (stage I and II).

SETTINGS AND DESIGN

Prospective, double arm, phase 2, randomized study.

MATERIALS AND METHODS

Sixty patients of squamous cell carcinoma oropharynx (stage I and II) were randomized in two arms (accelerated fractionation, arm 1 and conventional fractionation, arm 2). All patients received RT dose of 66 Gray (Gy) in 33 fractions (#). The patients in arm 1 received six fractions per week with 2 Gy/# (Monday-Saturday) and in arm 2, five fractions per week with 2 Gy/# (Monday-Friday). No chemotherapy was administered. During and after the treatment, locoregional control, and acute and late radiation toxicity were assessed.

RESULTS

At 1-year follow-up, 76% patients in arm 1 and 64% patients in arm 2 had complete response. The recurrence rate at the end of 1 year in arm 1 was 12% and it was 20% in arm 2.The acute Grade 2 and 3 toxicities were higher in the accelerated arm and no significant difference in late toxicities was found. SPSS version 4.0 was used for statistical analysis.

CONCLUSION

Accelerated fractionation provides better locoregional control with higher but acceptable acute and equal late radiation toxicity in squamous cell carcinoma oropharynx.

摘要

背景

头颈部癌的放疗剂量和分割方案在局部区域控制及可接受的器官毒性方面仍存在争议。加速放疗包括每周给予六次分割照射,每次分割剂量相同。

目的

比较常规放疗与加速放疗在口咽鳞状细胞癌(I期和II期)的局部区域控制、急性和晚期放射毒性方面的差异。

设置与设计

前瞻性、双臂、2期随机研究。

材料与方法

60例口咽鳞状细胞癌(I期和II期)患者被随机分为两组(加速分割组,第1组;常规分割组,第2组)。所有患者均接受33次分割照射,总剂量66格雷(Gy)。第1组患者每周接受6次分割照射,每次2 Gy(周一至周六);第2组患者每周接受5次分割照射,每次2 Gy(周一至周五)。未给予化疗。在治疗期间及治疗后,评估局部区域控制情况、急性和晚期放射毒性。

结果

在1年随访时,第1组76%的患者和第2组64%的患者达到完全缓解。第1组1年末的复发率为12%,第2组为20%。加速分割组的急性2级和3级毒性较高,晚期毒性无显著差异。使用SPSS 4.0版进行统计分析。

结论

在口咽鳞状细胞癌中,加速分割放疗可提供更好的局部区域控制,急性放射毒性较高但可接受,晚期放射毒性相当。

相似文献

1
Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.口咽I期和II期鳞状细胞癌中传统分割放疗(每周五次分割)与改变分割放疗(每周六次分割)的比较:一项机构研究
Indian J Cancer. 2017 Jan-Mar;54(1):6-10. doi: 10.4103/ijc.IJC_144_17.
2
Comparison of two different radiation fractionation schedules with concurrent chemotherapy in head and neck malignancy.两种不同放疗分割方案联合同步化疗治疗头颈部恶性肿瘤的比较。
Indian J Cancer. 2016 Apr-Jun;53(2):265-269. doi: 10.4103/0019-509X.197740.
3
Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.传统放疗、加速超分割放疗与同步放化疗治疗局部晚期口咽癌的长期疗效比较
Tumori. 2006 Jan-Feb;92(1):41-54. doi: 10.1177/030089160609200108.
4
Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.改变分割放疗与传统分割放疗对喉、口咽和下咽鳞状细胞癌患者局部区域控制及生存的影响
Croat Med J. 2006 Feb;47(1):42-52.
5
Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.晚期头颈癌加速分割放疗方案两种变体的随机I/II期试验:RTOG 88-09的结果
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):589-97. doi: 10.1016/0360-3016(95)00078-D.
6
Prospective randomized trial to compare accelerated (six fractions a week) radiotherapy against concurrent chemoradiotherapy (using conventional fractionation) in locally advanced head and neck cancers.一项前瞻性随机试验,比较局部晚期头颈癌患者接受加速放疗(每周六次分割)与同步放化疗(采用常规分割)的疗效。
J Cancer Res Ther. 2015 Oct-Dec;11(4):723-9. doi: 10.4103/0973-1482.147729.
7
Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.RTOG9003 局部区域控制和晚期毒性的最终结果:局部晚期头颈部癌改变分割放疗的随机试验。
Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):13-20. doi: 10.1016/j.ijrobp.2013.12.027. Epub 2014 Mar 7.
8
[SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].同步放化疗联合顺铂治疗局部晚期头颈部鳞状细胞癌(SCHNC)。早期结果及毒性评估
Otolaryngol Pol. 2011 Sep;65(5 Suppl):117-25. doi: 10.1016/S0030-6657(11)70719-3.
9
A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.头颈部III期和IV期鳞状细胞癌加速放疗与传统放疗的随机试验:一项跨塔斯曼放射肿瘤学组研究
Radiother Oncol. 2001 Aug;60(2):113-22. doi: 10.1016/s0167-8140(01)00347-4.
10
Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.同步整合加量调强放射治疗局部晚期头颈部鳞状细胞癌:II期临床结果
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87. doi: 10.1016/j.ijrobp.2004.03.010.

引用本文的文献

1
A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies.非手术癌症治疗引起的唾液腺功能减退和/或口干症的系统评价:预防策略
Support Care Cancer. 2025 Jan 10;33(2):87. doi: 10.1007/s00520-024-09113-x.
2
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.治疗口腔和口咽癌的干预措施:化疗。
Cochrane Database Syst Rev. 2021 Dec 20;12(12):CD006386. doi: 10.1002/14651858.CD006386.pub4.